Key result
The atherogenic index of plasma (AIP) was an independent risk factor and predicted the occurrence of microalbuminuria in newly diagnosed type 2 diabetes mellitus patients (AUC 0.772, P<0.05).
Why the study?
The predictive value of the atherogenic index of plasma for microalbuminuria in newly diagnosed type 2 diabetes mellitus patients needed to be explored.
Does the plasma atherogenic index predict microalbuminuria in newly diagnosed patients with type 2 diabetes mellitus?
Population
335 newly diagnosed T2DM patients
Comparison
Microalbuminuria vs no microalbuminuria
Design
Retrospective study
Authors
Loading...
AIP may support early microalbuminuria risk stratification in new T2DM; hypothesis-generating and requires prospective validation before practice change.
Observational (n=335)
Does the plasma atherogenic index predict microalbuminuria in newly diagnosed patients with type 2 diabetes mellitus?
Effect estimate: AUC 0.772
p-value: p=<0.05
AIP is an independent risk factor and useful predictor for the occurrence of microalbuminuria in newly diagnosed T2DM patients.
Qi et al. (2022) conducted an observational in Newly diagnosed type 2 diabetes mellitus (n=335). Atherogenic index of plasma (AIP) was evaluated on Microalbuminuria (MAU) (AUC 0.772, p=<0.05). The atherogenic index of plasma (AIP) was an independent risk factor and predicted the occurrence of microalbuminuria in newly diagnosed type 2 diabetes mellitus patients (AUC 0.772, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: